Business Wire (Tue, 8:30AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 8, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Apr 23, 2013)
-
Business Wire (Apr 22, 2013)
-
-
-
Business Wire (Mar 14, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 13, 2013)
-
Business Wire (Jan 23, 2013)
-
Business Wire (Jan 9, 2013)
-
To learn more about Seeking Alpha Pro, click here.
-
Ligand Pharmaceuticals' Insider Buys Continue Ahead Of New CatalystsM. E. Garza • Wed, Nov 2, 2011 -
Ligand Pharmaceuticals: Loeb's ThirdPoint Cuts Stake, Books ProfitsLon Juricic • Thu, Mar 29, 2007
-
-
-
-
-
-
What Moves Biotech Stocks? Ed Arce Has AnswersLife Sciences Report • Thu, Oct 18, 2012
-
-
-
-
-
-
-
Biotechnology And Drugs Stocks To Watch For Next WeekStockPandit • Wed, Apr 25, 2012
-
-
-
-
-
-
-
-
Ligand Pharmaceuticals Inc. Q2 2009 Earnings Call TranscriptMon, Aug 3, 2009
-
Ligand Pharmaceuticals Inc. Q1 2009 Earnings Call TranscriptWed, May 6, 2009
-
Ligand Pharmaceuticals Incorporated Q4 2008 Earnings Call TranscriptThu, Feb 12, 2009
-
Ligand Pharmaceuticals, Inc. Q3 2008 Earnings Call TranscriptThu, Nov 20, 2008
-
Ligand Pharmaceuticals, Inc. Q2 2008 Earnings Call TranscriptMon, Aug 25, 2008
-
Ligand Pharmaceuticals Incorporated Q1 2008 Earnings Call TranscriptTue, May 20, 2008
-
Ligand Pharmaceuticals Q4 2007 Earnings Call TranscriptWed, Feb 20, 2008
-
Business Wire (Tue, 8:30AM)
-
Business Wire (May 8, 2013)
-
Business Wire (Apr 30, 2013)
-
Business Wire (Apr 23, 2013)
-
Business Wire (Apr 22, 2013)
-
Business Wire (Mar 14, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 13, 2013)
-
Business Wire (Jan 23, 2013)
-
Business Wire (Jan 9, 2013)
-
Business Wire (Nov 27, 2012)
-
at CNBC.com (Nov 19, 2012)
-
Business Wire (Nov 19, 2012)
-
Business Wire (Nov 13, 2012)
-
Business Wire (Nov 5, 2012)
-
Business Wire (Nov 5, 2012)
LGND vs. ETF Alternatives
Company Description
We are a biotechnology company that focuses on drug discovery and early-stage development of pharmaceuticals that address critical unmet medical needs or that are more effective and/or safer than existing therapies, more convenient to administer and are cost effective. Our goal is to build a... More
